Hassan Rahimi Koshkaki

Pubblicazioni

Titolo Pubblicato in Anno
Prompt D$^{0}$, D$^{+}$, and D$^{*+}$ production in Pb-Pb collisions at $\sqrt{s_{\rm NN}}$ = 5.02 TeV JOURNAL OF HIGH ENERGY PHYSICS 2021
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma JOURNAL OF PERSONALIZED MEDICINE 2020
Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type Lectin (MGL) CANCERS 2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients JOURNAL OF PERSONALIZED MEDICINE 2020
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells EBIOMEDICINE 2020
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells ANNALS OF ONCOLOGY 2020
Exploration of jet substructure using iterative declustering in pp and Pb–Pb collisions at LHC energies PHYSICS LETTERS. SECTION B 2020
{(Anti-)deuteron production in pp collisions at $\sqrt{s}=13 \ \text {TeV}$} THE EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2020
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients JOURNAL OF PERSONALIZED MEDICINE 2020
Bevacizumab-based chemotherapy triggers Immunological effects in responding multi-treated recurrent ovarian cancer patients by favoring the recruitment of effector T Cell Subsets JOURNAL OF CLINICAL MEDICINE 2019
Anisakis pegreffii impacts differentiation and function of human dendritic cells PARASITE IMMUNOLOGY 2018
TK inhibitor pazopanib primes DCs by downregulation of the β-catenin pathway CANCER IMMUNOLOGY RESEARCH 2018
The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer. A meta-analysis GYNECOLOGIC ONCOLOGY 2018
Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells FRONTIERS IN IMMUNOLOGY 2018
Tumor-derived microvesicles modulate antigen cross-processing via reactive oxygen species-mediated alkalinization of phagosomal compartment in dendritic cells FRONTIERS IN IMMUNOLOGY 2017
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients JOURNAL OF CLINICAL ONCOLOGY 2017
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial INTERNATIONAL JOURNAL OF ONCOLOGY 2016
The macrophage Galactose-type C-type Lectin (MGL) modulates regulatory T cell functions PLOS ONE 2015
MGL receptor and immunity: when the ligand can make the difference JOURNAL OF IMMUNOLOGY RESEARCH 2015

ERC

  • LS4_12
  • LS6_3
  • LS7_2

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

My main research interest

- Study of immune response in cancer patients (glioblastoma, ovarian cancer);

- Characterization and generation of Dendritic Cell vaccine for immunotherapeutic strategies

- Extracellular vesicle isolation and characterization in tumor microenvironment cross-talk

 

Keywords

DCs
anti-tumor immunity
monoclonal antibody
DC vaccine
enzyme
Extracellular Vesicles
antigen processing and presentation

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma